Hollis-Eden Pharmaceuticals
Officials at Hollis-Eden Pharmaceuticals discuss recent developments
Published in Medical Verdicts and Law Weekly, January 18th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Hollis-Eden Pharmaceuticals.
Report 1: Hollis-Eden Pharmaceuticals, Inc., (HEPH) provided an update on its progress in negotiations with the U.S. Department of Health & Human Services (HHS) on a potential BioShield procurement contract for Neumune, the company's lead drug candidate for Acute Radiation Syndrome (ARS).
As previously announced, Hollis-Eden was informed by HHS in late June the company "is within the competitive range for discussion and further...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Awards
Neuropharma receives Frost & Sullivan International Excellence in Technology award - Business & Finance
Genmab discloses details of the issue of shares to GlaxoSmithKline - Business Update
Advancis closes private placement of common equity, files application for Pulsys - Business Update
Analytical Spectral Devices launches portable drug anti-counterfeiting technology - Business Update
Anchen announces approval of generic version of Wellbutrin XL - Business Update
Mergers and acquisitions firm MidMarket Capital advises Van Slyck on sale to Eclipsys - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
